Introduction
Thoracic endometriosis syndrome (TES) is one of the extrapelvic forms of endometriosis, and it can involve the airways, pleura and lung parenchyma. This rare condition includes four entities: catamenial pneumothorax, catamenial hemothorax, catamenial hemoptysis and lung nodules.
1,2
Considered an extremely exceptional condition, the TES diagnosis is repeatedly delayed and, many times, confounded with other diseases, mainly when it is presented as hemoptysis, which is even rarer. The literature evidence about TES is very sparse and most of the findings come from case reports, which suggests an important limitation regarding the data.
2,3
Cyclic manifestations of pulmonary diseases, such as chest or shoulder pain, dyspnea and hemoptysis, which occur along with the menstrual period, should be considered as an alert for any gynecologist or clinician. In such cases, the hypothesis of TES should be seriously considered, and a further investigation with imaging techniques ought to be implemented for diagnosis, despite of nonspecific findings. Clinical management, due to its conservative character, should be considered as the first-line therapy, and the Keywords ► endometriosis ► hemoptysis ► thoracic endometriosis syndrome
Abstract
Thoracic endometriosis syndrome is a rare condition that includes four entities: catamenial pneumothorax, catamenial hemothorax, catamenial hemoptysis and lung nodules. We describe the case of a 23-year-old woman with complaints of hemoptysis during menstrual period in the two years prior to the appointment. Initially, a treatment for tuberculosis was established with no success. Further investigation showed a 4 mm nodule in the right lung, and the transvaginal ultrasonography indicated the presence of deep endometriosis. Considering the occurrence of symptoms only during menses, an empirical therapy was instituted with remission of the complaints.
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Resumo
A síndrome da endometriose torácica é uma condição rara que inclui quatro entidades: pneumotórax catamenial, hemotórax catamenial, hemoptise catamenial e nódulos pulmonares. Descrevemos o caso de uma mulher de 23 anos de idade com queixas de hemoptise durante o período menstrual por 2 anos. Inicialmente, um tratamento para a tuberculose foi estabelecido sem sucesso. Uma investigação adicional mostrou um nódulo de 4 mm no pulmão direito, e a ultrassonografia transvaginal indicou a presença de endometriose profunda. Considerando a ocorrência de sintomas somente durante a menstruação, uma terapia empírica foi instituída com remissão das queixas.
surgical approach must be cogitated when the pharmacological approach fails.
5,6
Case report
A 23-year-old woman presented with complaints of hemoptysis during the menstrual period, associated with pain in the right shoulder for the past 2 years, with no prior background of smoking or tuberculosis. At admission, her clinical examination and chest X-ray showed no abnormality. She was clinically treated for tuberculosis for several times; however, there was no remission of the symptoms. Taking into consideration that the hemoptysis occurred only during menses, an inquiry about endometriosis was performed, and the patient revealed that dyspareunia and dysmenorrhea were recurrent.
Further investigation with computed tomography (CT) scans during menses showed an area of ground glass haze in the upper lobe of the right lung (►Fig. 1) and for a better inquiry, a bronchoscopy was performed between menses, and the bronchial washing turned to be negative. As a complementary investigation, the patient underwent transvaginal ultrasonography to investigate the presence of pelvic endometriosis, which was a positive finding. Endometriosis was apparently affecting the posterior fornix and the sacral-uterine ligament. Considering the emergence of symptoms during menses, an empirical treatment with Dienogest (2mg/day) was established.
The first follow-up took place two months after the beginning of therapy, and the patient was clinically asymptomatic. A control CT scan was performed and revealed a current recovery of the affected area (►Fig. 2). After the oneyear follow-up, the patient remains clinically asymptomatic. 
Discussion
Endometriosis is an estrogen-dependent inflammatory disease that is pronounced by the presence of endometrial tissue outside the uterus, affecting several structures and organs, such as the rectosigmoid colon, rectovaginal septum, uterosacral ligament, bladder and even extrapelvic organs.
7
1,2
The most usual appearance of TES is catamenial pneumothorax (73%), and the rarest is catamenial hemoptysis, jointly with lung nodules (6% each), as we see in our patient who presents both nodule and hemoptysis.
5,8
Many theories attempt to clarify the presence of extrapelvic endometrial implants, including intrathoracic implants. Among these theories is coelomic metaplasia, which is based on the hypothesis that both endometrium and pleura have the same embryologic origin, and pathogenic incitements could induce precursor cells to differentiate into endometrial cells.
7
Another widespread theory, lymphatic or hematogenic dissemination, would also elucidate the occurrence of extrapelvic endometriosis, including TES, and its propensity to the right lung since the right lymphatic drainage system is more complex than the left hemithorax.
2,7
Clinical manifestation of TES is exceedingly uncommon, and most of the data on this syndrome come from case reports and a retrospective study including 110 patients. Joseph J. et al showed that the mean age at the onset of symptoms was 35 years old and the peak incidence for TES occurred 5 years after the incidence of pelvic endometriosis in these patients.
8
Contrary to what the literature shows, our patient presented both symptoms, pelvic pain and hemoptysis, at the same time, and the main symptom presented by our patient, cyclical hemoptysis, an extremely rare condition, has been described in 30 cases in the literature. Thoracic endometriosis syndrome is considered a thought-provoking diagnostic due to its undefined symptoms, and there is an enormous delay until the disclosure of the diagnosis. Cyclical and recurrent complaints, such as shoulder and chest pain, hemoptysis and dyspnea, mainly when related with pelvic endometriosis background, ought to ring a bell about TES.
5,10
Not only clinical but also imaging aspects are openended, even though CT endures as the first-line imaging exam, enabling exclusion of many other lung diseases with similar symptoms and also assisting with the diagnosis in patients with significant clinical description. Magnetic resonance imaging is considered superior to CT, as it can notice blood and its products when performed during menses.
Bronchoscopy has a limited role in diagnosis, since most pathologic features are situated in the areas around the lung;
as we see in our case reported, the bronchoscopy was completely normal. Regarding video-assisted thoracoscopy, a direct imagining of lung parenchyma, pleura and diaphragmatic shell offers a precise diagnostic.
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Considering that there is no definitive treatment for endometriosis, in general, one has to cogitate options for a long-term management. Frequently, hormonal overthrow is the first option in the attempt to control symptoms caused by endometriosis and to postpone or even avoid surgical treatment due to great morbidity.
11-13
Surgical management by thoracoscopy, or even thoracotomy, aims to remove all the endometriotic tissue and sometimes, a pulmonary segmentectomy is required. This treatment is regarded when clinical approach fails.
6-14
A variety of drugs has been used to treat endometriosis, including TES, such as combined oral contraceptives, progestogens and gonadotropin-releasing hormone (GnRH) agonists, and all of them have presented comparable usefulness. Safety, acceptability and cost need to be considered in order to implement a long-term treatment.
11
Dienogest, a fourth-generation progestogen, has been reported as an effective drug in the treatment of complaints caused by endometriosis, acting through inhibition of GnRH, inducing estrogen deprivation and causing decidualization and atrophy of endometriotic lesions with few and very tolerable side effects.
12,15
As we see in the case reported, after the treatment with dienogest (2 mg/day), our patient remained completely asymptomatic and had no further episodes of hemoptysis or pelvic pain.
In conclusion, TES is a rare disorder that is commonly missed or whose diagnosis is delayed. It may be suspected in women with symptoms during the menstrual period. Computed tomography scan has an important role in presumptive diagnosis. Surgical treatment is an option in some cases; however, the clinical treatment is very effective and suppresses endometriotic tissue growth.
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